Iolanda Donatella Vincelli

Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

Michèle Cavo, Francesca Gay, Meral Beksaç et al. · The Lancet Haematology · 2020 · 377 citations · Full text

Hematological Malignancy, Transplantation, Marrow Transplantation +9

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

Davide Rossi, Lodovico Terzi-di-Bergamo, Lorenzo De Paoli et al. · Blood · 2015 · 212 citations · Full text

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival

Antonio Palumbo, Sara Bringhen, Alessandra Larocca et al. · Journal of Clinical Oncology · 2014 · 210 citations · Full text

Health‐related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease

Fabio Efficace, Franco Mandelli, Paola Fazi et al. · American Journal of Hematology · 2016 · 80 citations · Full text

Quality of life in elderly patients with acute myeloid leukemia: patients may be more accurate than physicians

Esther Natalie Olíva, Francesco Nobile, G. Alimena et al. · Haematologica · 2011 · 74 citations · Full text